BSE filing, NSE: ADROITINFO. Summary written from the filing by ALFA Finder's alert engine.
Adroit Infotech Ltd: key numbers
- Share price
- ₹12.44
- Market cap
- ₹68.73 Cr
- Revenue (annual)
- ₹48.66 Cr
- Net profit (annual)
- ₹3.30 Cr
- P/E (TTM)
- 22.2×Sector 23.0×
- Promoter holding
- 43.03%+0.04% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Adroit Infotech Ltd
All →Adroit Infotech Board Meeting Date
Adroit Infotech Limited intimates a board meeting on 04 Nov 2026 to approve unaudited standalone and consolidated results for the half year ended 30 September 2026. The results are not yet approved, so no figures are reported.
Adroit Infotech Merger & Restructuring
Adroit Infotech signed a non-binding agreement to acquire a majority stake in Croatia-based Verso Altima Group d.o.o. The strategic deal aims to expand its international presence.
Adroit Infotech Acquisition
Adroit Infotech Limited entered a non-binding agreement to acquire a majority stake in Croatia-based Verso Altima Group d.o.o. to strengthen its global SAP services capabilities.
Adroit Infotech Employee Stock Options
Adroit Infotech Ltd appointed trustees and approved the trust deed to implement the AIL ESOP-2023 Scheme. These administrative steps establish the ESOP trust structure.
Adroit Infotech Board Meeting Date
Adroit Infotech Ltd has scheduled a board meeting on October 3, 2026, to discuss the implementation of the Employee Welfare Trust and ESOP-2023.
Adroit Infotech Results Correction
Adroit Infotech clarified an XBRL-PDF discrepancy in Q4 FY26 results. The company revised its XBRL filing to align OCI with approved PDF statements.
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.